,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Pain,3,16826133
0,22.0,Limb injury,2,16826154
1,22.0,Flushing,2,16826154
2,22.0,Medication error,6,16826154
3,22.0,Oedema,2,16826154
4,22.0,Administration site extravasation,2,16826154
0,22.1,Prostatic specific antigen increased,2,16826203
1,22.1,Anaemia,1,16826203
2,22.1,Dehydration,6,16826203
3,22.1,Hepatic lesion,6,16826203
0,22.1,Renal cancer stage IV,5,16826263
1,22.1,Asthenia,6,16826263
0,22.0,Agranulocytosis,1,16826289
0,22.0,Blood pressure increased,2,16826300
1,22.0,Hypophagia,6,16826300
2,22.0,Constipation,6,16826300
0,22.0,Aortic stenosis,6,16826320
1,22.0,Fluid retention,6,16826320
2,22.0,Asthenia,6,16826320
3,22.0,Hypotension,6,16826320
4,22.0,Blood count abnormal,6,16826320
5,22.0,Acute kidney injury,5,16826320
0,22.0,Malignant neoplasm progression,5,16826321
0,22.1,Back pain,,16826322
0,22.0,Iron deficiency anaemia,6,16826453
1,22.0,Neutropenia,6,16826453
2,22.0,Neoplasm progression,6,16826453
3,22.0,Blood loss anaemia,6,16826453
0,22.0,Arrhythmia,6,16826454
1,22.0,Cardiac disorder,6,16826454
2,22.0,Fatigue,6,16826454
0,22.0,Limb mass,6,16826457
1,22.0,Cancer pain,6,16826457
2,22.0,Peripheral swelling,6,16826457
0,22.0,Abdominal distension,6,16826460
1,22.0,Pleural effusion,6,16826460
2,22.0,White blood cell count decreased,6,16826460
3,22.0,Disturbance in attention,6,16826460
4,22.0,Nausea,6,16826460
5,22.0,Fatigue,6,16826460
6,22.0,Balance disorder,6,16826460
7,22.0,Feeling abnormal,6,16826460
8,22.0,Neutrophil count decreased,6,16826460
0,22.1,Leukopenia,1,16826465
1,22.1,Septic shock,1,16826465
2,22.1,Thrombocytopenia,1,16826465
3,22.1,Anaemia,3,16826465
0,22.0,Arthralgia,6,16826475
1,22.0,Back pain,6,16826475
2,22.0,Pain in extremity,6,16826475
3,22.0,Radicular pain,6,16826475
4,22.0,Diarrhoea,6,16826475
5,22.0,Nausea,6,16826475
6,22.0,Spinal pain,6,16826475
7,22.0,Muscle oedema,6,16826475
8,22.0,Muscle rupture,6,16826475
0,22.0,Cerebrovascular accident,3,16826476
1,22.0,Hypoaesthesia,1,16826476
0,22.0,Atrial fibrillation,5,16826479
1,22.0,Haemoptysis,5,16826479
2,22.0,Respiratory failure,5,16826479
3,22.0,Hypovolaemia,5,16826479
4,22.0,Acute kidney injury,5,16826479
5,22.0,Pyrexia,5,16826479
0,22.0,Nervousness,2,16826496
1,22.0,Malaise,2,16826496
0,22.0,Death,5,16826509
0,22.0,Neoplasm progression,6,16826516
1,22.0,Hydrothorax,6,16826516
2,22.0,Ascites,6,16826516
0,22.0,Neuropathy peripheral,3,16826525
0,22.0,Death,5,16826528
0,22.0,Death,5,16826529
0,22.0,Death,5,16826533
1,22.0,Neoplasm progression,6,16826533
0,22.0,Death,5,16826536
0,22.0,Fall,5,16826652
1,22.0,Cardiac death,5,16826652
0,22.0,Lung disorder,6,16826675
0,22.0,Immune-mediated enterocolitis,6,16826711
1,22.0,Sjogren^s syndrome,6,16826711
2,22.0,Autoimmune thyroiditis,6,16826711
0,22.0,Sjogren^s syndrome,6,16826713
0,22.0,Sjogren^s syndrome,6,16826726
0,22.1,Mitral valve incompetence,3,16826749
1,22.1,Mitral valve prolapse,1,16826749
0,22.1,Ejection fraction decreased,1,16826750
1,22.1,Mitral valve incompetence,1,16826750
2,22.1,Hypertension,1,16826750
0,22.0,Eczema,1,16826751
1,22.0,Interstitial lung disease,1,16826751
0,22.0,Death,5,16826754
1,22.0,Neoplasm progression,6,16826754
0,22.0,Death,5,16826757
1,22.0,Neoplasm progression,6,16826757
0,22.0,Capillary leak syndrome,1,16826758
0,22.0,Death,5,16826761
0,22.0,Death,5,16826762
1,22.0,Neoplasm progression,6,16826762
0,22.1,Pneumonia,5,16826780
1,22.1,Malignant neoplasm progression,6,16826780
0,22.0,Death,5,16826791
0,22.1,Death,5,16826792
0,22.1,Death,5,16826807
0,22.0,Skin odour abnormal,6,16826809
0,22.1,Radiation pneumonitis,2,16826827
0,22.0,Pneumonitis,1,16826851
1,22.0,Multiple organ dysfunction syndrome,5,16826851
2,22.0,Cardiac dysfunction,3,16826851
3,22.0,Thrombocytopenia,3,16826851
0,22.1,Prostate cancer,5,16826868
1,22.1,Cardiac failure congestive,6,16826868
0,22.0,Drug ineffective,3,16826882
1,22.0,Anaemia,3,16826882
0,22.0,Death,5,16826905
0,22.0,Prostate cancer metastatic,6,16826916
1,22.0,Death,5,16826916
2,22.0,Mobility decreased,6,16826916
3,22.0,Fall,6,16826916
4,22.0,Dysuria,6,16826916
0,22.0,Palatal disorder,2,16826957
1,22.0,Sinusitis,1,16826957
2,22.0,Nasal septum deviation,1,16826957
0,22.1,Prostate cancer,5,16826964
0,22.0,Myocardial ischaemia,3,16826971
1,22.0,Pleural effusion,6,16826971
2,22.0,Sinus tachycardia,6,16826971
3,22.0,Lung disorder,6,16826971
4,22.0,Hepatic function abnormal,6,16826971
5,22.0,Interstitial lung disease,6,16826971
6,22.0,Bone pain,6,16826971
7,22.0,Intra-abdominal fluid collection,6,16826971
0,22.1,Metastatic gastric cancer,5,16826995
1,22.1,Neutrophil count decreased,3,16826995
2,22.1,White blood cell count decreased,3,16826995
3,22.1,Pyrexia,6,16826995
0,22.1,Diabetic ketoacidosis,6,16827031
0,22.1,Troponin increased,6,16827032
1,22.1,Pneumonia,5,16827032
2,22.1,Chest discomfort,6,16827032
3,22.1,Condition aggravated,5,16827032
4,22.1,Pulmonary alveolar haemorrhage,5,16827032
5,22.1,Respiratory failure,6,16827032
6,22.1,Oxygen saturation abnormal,5,16827032
0,22.1,Left ventricular dysfunction,6,16827048
1,22.1,Ejection fraction decreased,6,16827048
0,22.0,Inflammation,6,16827077
1,22.0,Swelling,6,16827077
2,22.0,Erysipelas,1,16827077
3,22.0,Visual impairment,3,16827077
0,22.0,Post procedural haemorrhage,,16827118
0,22.0,Autoimmune thyroiditis,6,16827143
1,22.0,Sjogren^s syndrome,6,16827143
2,22.0,Immune-mediated pneumonitis,6,16827143
0,22.0,Agranulocytosis,1,16827151
0,22.0,Agranulocytosis,1,16827154
0,22.0,Emergency care,6,16827166
1,22.0,Onychomalacia,6,16827166
2,22.0,Alopecia,6,16827166
3,22.0,Skin exfoliation,6,16827166
4,22.0,Yellow skin,6,16827166
5,22.0,Ocular icterus,,16827166
6,22.0,Chromaturia,,16827166
7,22.0,Off label use,,16827166
0,22.0,Bone density decreased,,16827177
1,22.0,Hormone-refractory prostate cancer,,16827177
2,22.0,Fall,,16827177
3,22.0,Metastases to bone,,16827177
4,22.0,Bone pain,3,16827177
5,22.0,Traumatic fracture,3,16827177
0,22.0,Herpes zoster,2,16827287
0,22.1,Blood cholesterol increased,3,16827300
1,22.1,Blood triglycerides increased,3,16827300
0,22.0,Drug interaction,6,16827357
1,22.0,Anaemia,1,16827357
2,22.0,Thrombocytopenia,1,16827357
0,22.0,Metastases to liver,2,16827362
1,22.0,Drug ineffective,6,16827362
2,22.0,Skin cancer,1,16827362
0,22.0,Osteonecrosis of jaw,2,16827394
1,22.0,Mouth haemorrhage,1,16827394
2,22.0,Hypovolaemic shock,2,16827394
0,22.1,Flushing,,16827398
1,22.1,Dyspnoea,,16827398
2,22.1,Infusion related reaction,,16827398
0,22.0,Face oedema,1,16827404
0,22.0,Fatigue,,16827415
0,22.0,Hair texture abnormal,3,16827495
1,22.0,Hair disorder,3,16827495
2,22.0,Hair colour changes,3,16827495
3,22.0,Alopecia,3,16827495
0,22.1,Hair disorder,3,16827499
1,22.1,Hair colour changes,3,16827499
2,22.1,Hair texture abnormal,3,16827499
3,22.1,Alopecia,3,16827499
0,22.0,Neoplasm progression,6,16827522
0,22.0,White blood cell count decreased,6,16827525
0,22.0,Depressed level of consciousness,1,16827568
0,22.1,Interstitial lung disease,2,16827595
0,22.0,Death,5,16827598
0,22.1,White blood cell count decreased,6,16827635
1,22.1,Neutrophil count decreased,6,16827635
0,22.0,Neoplasm progression,6,16827639
0,22.1,Hair colour changes,3,16827645
1,22.1,Madarosis,3,16827645
2,22.1,Hair disorder,3,16827645
3,22.1,Alopecia,3,16827645
4,22.1,Hair texture abnormal,3,16827645
0,22.1,Stent placement,,16827646
0,22.1,Device malfunction,6,16827671
1,22.1,Blood count abnormal,6,16827671
2,22.1,Death,5,16827671
0,22.0,White blood cell count decreased,6,16827702
0,22.0,Renal impairment,3,16827712
0,22.0,Insomnia,6,16827735
1,22.0,Headache,6,16827735
2,22.0,Fatigue,6,16827735
0,22.1,Arthralgia,6,16827743
0,22.1,Fatigue,6,16827752
1,22.1,White blood cell count decreased,6,16827752
2,22.1,Alopecia,6,16827752
0,22.0,Malaise,6,16827753
0,22.0,Muscle spasms,6,16827755
0,22.0,Pneumonitis,1,16827756
0,22.1,Disease progression,,16827767
0,22.0,Acute polyneuropathy,3,16827782
1,22.0,Metastases to liver,3,16827782
2,22.0,Balance disorder,1,16827782
3,22.0,General physical health deterioration,1,16827782
0,22.1,Diarrhoea,1,16827804
1,22.1,Lung disorder,1,16827804
2,22.1,Pyrexia,1,16827804
0,22.1,Urinary tract infection,,16827819
1,22.1,Blood disorder,,16827819
0,22.1,Pain in extremity,,16827827
1,22.1,Skin exfoliation,,16827827
2,22.1,Erythema,,16827827
0,22.1,Death,,16827836
0,22.1,Decreased appetite,,16827846
1,22.1,Asthenia,,16827846
2,22.1,Vomiting,,16827846
0,22.1,Flatulence,,16827865
1,22.1,Eructation,,16827865
2,22.1,Abdominal distension,,16827865
3,22.1,Gastrointestinal pain,,16827865
0,22.0,Neutropenia,6,16827884
0,22.0,Malaise,6,16827905
0,22.1,Malaise,5,16827936
1,22.1,Oedema,5,16827936
2,22.1,Death,5,16827936
3,22.1,Somnolence,5,16827936
4,22.1,Eczema,5,16827936
5,22.1,Lymphatic disorder,5,16827936
6,22.1,Movement disorder,5,16827936
7,22.1,Peripheral swelling,5,16827936
0,22.1,Fall,,16827951
1,22.1,Fatigue,,16827951
2,22.1,Blood potassium decreased,,16827951
3,22.1,Blood sodium decreased,,16827951
0,22.0,Hypoacusis,6,16827958
0,22.1,Hospitalisation,,16827973
1,22.1,Therapy cessation,,16827973
0,22.1,Pericarditis constrictive,3,16828018
1,22.1,Pericarditis,2,16828018
2,22.1,Myocarditis,6,16828018
0,22.0,Autoimmune thyroiditis,6,16828019
1,22.0,Addison^s disease,6,16828019
2,22.0,Sjogren^s syndrome,6,16828019
0,22.1,Pancytopenia,5,16828028
1,22.1,Nausea,3,16828028
2,22.1,Off label use,6,16828028
3,22.1,Cardiotoxicity,5,16828028
4,22.1,Bone marrow failure,1,16828028
5,22.1,Product use in unapproved indication,6,16828028
6,22.1,Drug ineffective,5,16828028
0,22.1,Disease progression,,16828050
0,22.0,Drug resistance,6,16828053
1,22.0,Malignant neoplasm progression,6,16828053
0,22.1,Death,,16828062
0,22.0,Anaphylactic reaction,1,16828159
0,22.1,Acute kidney injury,1,16828165
1,22.1,Sudden death,5,16828165
0,22.0,Capillary leak syndrome,1,16828169
0,22.1,Death,5,16828181
1,22.1,Pyrexia,6,16828181
2,22.1,Radiation injury,6,16828181
0,22.0,Metastases to meninges,6,16828258
0,22.1,Autoimmune hepatitis,3,16828259
1,22.1,Drug-induced liver injury,3,16828259
0,22.0,Death,5,16828298
0,22.1,Acute myocardial infarction,1,16828337
1,22.1,Acute coronary syndrome,1,16828337
0,22.1,Pemphigoid,6,16828338
0,22.1,Disease progression,,16828347
0,22.0,Leukopenia,2,16828352
1,22.0,Agranulocytosis,2,16828352
0,22.0,Agranulocytosis,2,16828355
0,22.0,Agranulocytosis,1,16828357
0,22.0,Agranulocytosis,1,16828359
0,22.0,Leukopenia,1,16828360
1,22.0,Agranulocytosis,1,16828360
0,22.0,Agranulocytosis,1,16828363
1,22.0,Leukopenia,1,16828363
0,22.0,Fatigue,6,16828365
0,22.1,Skin discolouration,,16828374
1,22.1,Fatigue,,16828374
0,22.1,White blood cell count decreased,,16828421
0,22.1,Cerebral infarction,1,16828429
1,22.1,Acute coronary syndrome,1,16828429
2,22.1,Malignant neoplasm progression,5,16828429
0,22.1,Pain,6,16828439
1,22.1,Impaired quality of life,6,16828439
2,22.1,Alopecia,2,16828439
3,22.1,Psychological trauma,6,16828439
4,22.1,Emotional distress,6,16828439
5,22.1,Anxiety,6,16828439
0,22.1,Alopecia,2,16828440
1,22.1,Psychological trauma,6,16828440
0,22.1,Impaired quality of life,6,16828494
1,22.1,Alopecia,3,16828494
2,22.1,Anxiety,6,16828494
3,22.1,Pain,6,16828494
4,22.1,Psychological trauma,6,16828494
5,22.1,Emotional distress,6,16828494
0,22.1,Alopecia,3,16828499
1,22.1,Pain,6,16828499
2,22.1,Impaired quality of life,6,16828499
3,22.1,Anxiety,6,16828499
4,22.1,Psychological trauma,6,16828499
5,22.1,Emotional distress,6,16828499
0,22.1,Anxiety,6,16828504
1,22.1,Emotional distress,6,16828504
2,22.1,Impaired quality of life,6,16828504
3,22.1,Pain,6,16828504
4,22.1,Alopecia,3,16828504
5,22.1,Psychological trauma,6,16828504
0,22.1,Psychological trauma,6,16828506
1,22.1,Alopecia,2,16828506
0,22.1,Alopecia,2,16828509
1,22.1,Emotional distress,6,16828509
2,22.1,Anxiety,6,16828509
3,22.1,Psychological trauma,6,16828509
4,22.1,Impaired quality of life,6,16828509
0,22.0,Adverse drug reaction,6,16828518
1,22.0,Dizziness,6,16828518
0,22.1,Atrial flutter,1,16828536
1,22.1,Drug hypersensitivity,6,16828536
0,22.1,Prostatic specific antigen increased,6,16828541
1,22.1,Fatigue,3,16828541
2,22.1,Hormone-refractory prostate cancer,3,16828541
0,22.1,Metastases to stomach,6,16828547
1,22.1,Haematocrit decreased,6,16828547
2,22.1,Ascites,3,16828547
3,22.1,Haemoglobin decreased,6,16828547
4,22.1,Asthenia,6,16828547
5,22.1,Peripheral swelling,3,16828547
6,22.1,Dyspnoea,3,16828547
7,22.1,Thrombocytopenia,6,16828547
8,22.1,Electrocardiogram QT prolonged,1,16828547
9,22.1,Anaemia,6,16828547
10,22.1,Hepatic cirrhosis,6,16828547
11,22.1,Metastases to bone,6,16828547
12,22.1,Red blood cell count decreased,6,16828547
13,22.1,Hypertension,6,16828547
14,22.1,Hyponatraemia,6,16828547
15,22.1,Neutropenia,1,16828547
16,22.1,Metastases to lymph nodes,6,16828547
17,22.1,Neutropenia,6,16828547
18,22.1,Thrombocytopenia,1,16828547
19,22.1,Alopecia,1,16828547
0,22.0,Renal disorder,6,16828569
0,22.0,Neoplasm progression,6,16828620
0,22.0,Head and neck cancer,3,16828662
0,22.1,Off label use,6,16828681
1,22.1,Leukopenia,2,16828681
2,22.1,Neutrophil count decreased,1,16828681
3,22.1,White blood cell count decreased,3,16828681
0,22.1,Vertigo,1,16828701
1,22.1,Angina pectoris,1,16828701
2,22.1,Blindness,4,16828701
3,22.1,Polyneuropathy,3,16828701
4,22.1,Dyspnoea exertional,3,16828701
5,22.1,Polyneuropathy,1,16828701
6,22.1,Vertigo,3,16828701
7,22.1,Headache,1,16828701
0,22.1,Cerebral infarction,1,16828703
1,22.1,Cerebellar haemorrhage,5,16828703
0,22.0,Gastrointestinal stoma complication,1,16828745
1,22.0,Diarrhoea,1,16828745
0,22.0,Sjogren^s syndrome,6,16828755
1,22.0,Immune-mediated hepatitis,6,16828755
0,22.0,Cancer pain,6,16828766
1,22.0,Musculoskeletal chest pain,6,16828766
0,22.0,Ovarian cancer,6,16828767
1,22.0,Recurrent cancer,6,16828767
0,22.0,Death,5,16828787
0,22.0,Cardiomyopathy,4,16828801
0,22.1,Prostate cancer metastatic,5,16828804
0,22.0,Swelling,6,16828820
1,22.0,Metastases to central nervous system,6,16828820
2,22.0,Malignant neoplasm progression,6,16828820
0,22.1,Viral infection,2,16828876
1,22.1,Hospitalisation,6,16828876
2,22.1,Dysphagia,6,16828876
0,22.0,Nephrolithiasis,1,16828883
0,22.0,Deafness,6,16828889
0,22.0,Menopause,6,16828890
1,22.0,Deafness,6,16828890
0,22.0,Deafness,6,16828891
1,22.0,Menopause,6,16828891
0,22.1,Anxiety,6,16828899
1,22.1,Pruritus,6,16828899
2,22.1,Product use in unapproved indication,6,16828899
3,22.1,Chest discomfort,6,16828899
4,22.1,Burning sensation,6,16828899
5,22.1,Rash,6,16828899
6,22.1,Vomiting,2,16828899
0,22.0,Toxicity to various agents,6,16828916
0,22.0,Menopause,6,16828928
1,22.0,Deafness,6,16828928
0,22.0,Deafness,6,16828933
1,22.0,Menopause,6,16828933
0,22.0,Chest discomfort,1,16828934
1,22.0,Oxygen saturation decreased,1,16828934
2,22.0,Rash,1,16828934
0,22.0,Deafness,6,16828935
1,22.0,Menopause,6,16828935
0,22.0,Muscular weakness,6,16829011
1,22.0,Muscle injury,6,16829011
2,22.0,Myocardial infarction,6,16829011
3,22.0,Myalgia,3,16829011
0,22.0,Oxygen saturation decreased,5,16829047
1,22.0,C-reactive protein increased,5,16829047
2,22.0,Pyrexia,5,16829047
3,22.0,Dyspnoea,5,16829047
4,22.0,Death,5,16829047
0,22.0,Cardiac disorder,6,16829078
0,22.0,Neuropathy peripheral,6,16829084
0,22.0,Inappropriate schedule of product administration,6,16829527
1,22.0,Visual impairment,6,16829527
0,22.1,Hepatic encephalopathy,1,16829528
0,22.1,Haemoptysis,6,16829637
1,22.1,Abdominal pain,6,16829637
2,22.1,Pyrexia,1,16829637
3,22.1,Melaena,6,16829637
4,22.1,Decreased appetite,2,16829637
5,22.1,Interstitial lung disease,5,16829637
0,22.0,Seizure,4,16829640
0,22.1,Death,5,16829644
0,22.0,Granulocytopenia,6,16829651
1,22.0,Second primary malignancy,1,16829651
2,22.0,Myelodysplastic syndrome,6,16829651
3,22.0,Graft versus host disease,6,16829651
4,22.0,Bronchopulmonary aspergillosis,6,16829651
5,22.0,Anaemia,6,16829651
6,22.0,Cytomegalovirus infection,6,16829651
7,22.0,Thrombocytopenia,6,16829651
0,22.0,Neoplasm progression,6,16829689
1,22.0,Death,5,16829689
0,22.0,Lipase increased,1,16829713
1,22.0,Oedema peripheral,1,16829713
2,22.0,Scrotal oedema,1,16829713
0,22.1,Malaise,6,16829742
1,22.1,Vomiting,1,16829742
2,22.1,Vomiting,1,16829742
3,22.1,Nausea,1,16829742
4,22.1,Abdominal pain upper,6,16829742
5,22.1,Pruritus,6,16829742
6,22.1,Dehydration,6,16829742
7,22.1,Asthenia,6,16829742
8,22.1,Liver function test increased,6,16829742
9,22.1,Aphthous ulcer,6,16829742
10,22.1,Saliva altered,1,16829742
11,22.1,Weight decreased,6,16829742
12,22.1,Gastrointestinal infection,1,16829742
13,22.1,Scratch,6,16829742
14,22.1,Diarrhoea,1,16829742
0,22.0,Hyperglycaemia,2,16829759
0,22.1,Product preparation error,6,16829770
1,22.1,Incorrect drug administration rate,6,16829770
2,22.1,Product dispensing error,6,16829770
3,22.1,No adverse event,6,16829770
4,22.1,Inappropriate schedule of product administration,6,16829770
0,22.1,Breast cancer metastatic,6,16829829
1,22.1,Malignant neoplasm progression,6,16829829
0,22.0,Vomiting,1,16829851
1,22.0,Pulmonary embolism,5,16829851
2,22.0,Abdominal pain,6,16829851
0,22.0,Iridocyclitis,6,16829853
1,22.0,Sjogren^s syndrome,6,16829853
2,22.0,Autoimmune thyroiditis,6,16829853
0,22.0,Decreased immune responsiveness,3,16829854
1,22.0,Red blood cell count decreased,3,16829854
2,22.0,Platelet count decreased,3,16829854
0,22.0,Death,5,16829872
0,22.0,Death,5,16829877
1,22.0,Neoplasm progression,6,16829877
0,22.0,Pyrexia,6,16829898
0,22.0,Ill-defined disorder,6,16829912
0,22.0,Mouth ulceration,6,16829913
1,22.0,Intra-abdominal fluid collection,6,16829913
2,22.0,Diarrhoea,6,16829913
0,22.1,Thrombocytopenia,1,16829943
0,22.0,Gingival blister,6,16830006
1,22.0,Stomatitis,3,16830006
2,22.0,Epistaxis,6,16830006
0,22.0,Agranulocytosis,1,16830100
0,22.0,Agranulocytosis,1,16830101
0,22.0,Agranulocytosis,1,16830102
0,22.0,Agranulocytosis,1,16830104
0,22.0,Agranulocytosis,1,16830105
0,22.0,Hepatic function abnormal,2,16830107
0,22.0,Pneumonia,5,16830113
1,22.0,Sepsis,5,16830113
0,22.0,Agranulocytosis,2,16830245
0,22.0,Disease progression,3,16830293
0,22.1,Hypophagia,6,16830295
1,22.1,Pneumonia,6,16830295
2,22.1,Idiopathic pulmonary fibrosis,6,16830295
0,22.0,Death,5,16830309
0,22.0,Hyperglycaemia,6,16830330
0,22.0,Dermatitis allergic,6,16830332
1,22.0,Therapy non-responder,6,16830332
0,22.0,Neuropathy peripheral,3,16830349
1,22.0,Bone marrow failure,3,16830349
2,22.0,Drug-induced liver injury,3,16830349
0,22.0,Metastases to liver,6,16830355
1,22.0,Malignant neoplasm progression,6,16830355
2,22.0,Colon cancer,6,16830355
3,22.0,Metastases to lung,6,16830355
0,22.1,Rash,1,16830397
0,22.1,Breast cancer male,6,16830406
0,22.0,Agranulocytosis,1,16830415
0,22.1,Tuberculosis,3,16830431
0,22.0,Dyspnoea,1,16830525
1,22.0,Intentional product use issue,6,16830525
0,22.0,Back pain,6,16830555
0,22.0,Liver injury,6,16830591
1,22.0,Faeces pale,6,16830591
2,22.0,Chromaturia,6,16830591
3,22.0,Fatigue,6,16830591
4,22.0,Jaundice cholestatic,3,16830591
0,22.1,Pulmonary embolism,1,16830601
1,22.1,Tachycardia,6,16830601
2,22.1,Dyspnoea,6,16830601
0,22.1,Pain,1,16830618
1,22.1,Product dose omission,6,16830618
2,22.1,Mobility decreased,1,16830618
3,22.1,Neck pain,1,16830618
4,22.1,Pain in jaw,1,16830618
0,22.0,Nausea,6,16830633
0,22.1,Myalgia,1,16830655
0,22.0,Fall,6,16830695
1,22.0,Fracture,6,16830695
0,22.1,Intentional product use issue,6,16830731
0,22.0,Agranulocytosis,1,16830758
0,22.0,Agranulocytosis,1,16830759
0,22.0,Agranulocytosis,1,16830760
0,22.0,Agranulocytosis,1,16830761
0,22.0,Agranulocytosis,1,16830762
0,22.0,Agranulocytosis,1,16830763
0,22.0,Leukopenia,1,16830764
1,22.0,Agranulocytosis,1,16830764
0,22.0,Death,5,16830817
1,22.0,Diabetes mellitus,6,16830817
0,22.1,Disease progression,5,16830818
1,22.1,Neutrophil count decreased,6,16830818
0,22.0,Papilloma viral infection,6,16830821
1,22.0,Breast cancer,6,16830821
2,22.0,Menopause,6,16830821
0,22.0,Agranulocytosis,1,16830838
0,22.0,Hepatic function abnormal,6,16830839
1,22.0,Bone marrow failure,6,16830839
0,22.0,Agranulocytosis,1,16830840
0,22.0,Agranulocytosis,1,16830841
0,22.0,Blood phosphorus decreased,1,16830866
1,22.0,Nausea,3,16830866
2,22.0,Diarrhoea,1,16830866
3,22.0,Decreased appetite,3,16830866
4,22.0,Vomiting,1,16830866
0,22.1,Lower respiratory tract infection,1,16830870
0,22.0,Diarrhoea,6,16830875
1,22.0,Disease progression,6,16830875
2,22.0,Myocardial infarction,6,16830875
3,22.0,Pruritus,6,16830875
0,22.0,Respiratory tract congestion,1,16830892
1,22.0,Cough,1,16830892
0,22.1,Device leakage,6,16830906
1,22.1,Accidental exposure to product,6,16830906
0,22.0,Diarrhoea,6,16830912
1,22.0,Nausea,6,16830912
2,22.0,Vomiting,6,16830912
3,22.0,Influenza like illness,6,16830912
4,22.0,Fatigue,6,16830912
5,22.0,Hypotension,6,16830912
6,22.0,Blood creatinine increased,6,16830912
7,22.0,Chills,6,16830912
0,22.0,Sleep disorder,6,16830930
1,22.0,Vomiting,1,16830930
2,22.0,Nausea,3,16830930
3,22.0,Decreased appetite,3,16830930
4,22.0,Death,5,16830930
5,22.0,Dyspnoea,3,16830930
6,22.0,Fatigue,3,16830930
0,22.0,Agranulocytosis,1,16830931
0,22.1,Erythema,1,16830932
1,22.1,Hypertensive crisis,1,16830932
2,22.1,Flushing,1,16830932
0,22.0,Dehydration,6,16830933
0,22.1,Diarrhoea,6,16830947
1,22.1,Metastases to meninges,6,16830947
2,22.1,Altered state of consciousness,6,16830947
0,22.0,Conjunctivitis,3,16830965
0,22.1,Nausea,2,16830975
1,22.1,Vomiting,2,16830975
2,22.1,Aphthous ulcer,2,16830975
0,22.1,Product use in unapproved indication,6,16830988
1,22.1,Large intestine perforation,6,16830988
0,22.1,Adverse event,6,16831048
0,22.1,Prostatic specific antigen increased,6,16831066
1,22.1,Epistaxis,6,16831066
2,22.1,Ageusia,6,16831066
3,22.1,Bladder disorder,6,16831066
0,22.0,Vision blurred,3,16831121
1,22.0,Strabismus,3,16831121
2,22.0,VIth nerve paralysis,3,16831121
0,22.0,Constipation,3,16831164
1,22.0,Weight increased,3,16831164
2,22.0,Hypertension,2,16831164
3,22.0,Fatigue,3,16831164
0,22.0,Renal impairment,3,16831166
0,22.1,Dizziness postural,1,16831205
0,22.0,Alopecia,6,16831232
1,22.0,Myalgia,6,16831232
2,22.0,Amenorrhoea,6,16831232
3,22.0,Asthenia,6,16831232
4,22.0,Anaemia,6,16831232
0,22.0,Abnormal faeces,2,16831323
1,22.0,Abnormal faeces,2,16831323
2,22.0,Colitis,2,16831323
0,22.1,Immune-mediated enterocolitis,1,16831324
0,22.1,Protein urine present,3,16831341
1,22.1,Urticaria,6,16831341
2,22.1,Cerebral infarction,6,16831341
3,22.1,Haemoptysis,6,16831341
4,22.1,Discomfort,6,16831341
5,22.1,Pneumonia,2,16831341
0,22.1,Fatigue,2,16831344
1,22.1,Dehydration,1,16831344
2,22.1,Asthenia,2,16831344
3,22.1,Vomiting,2,16831344
4,22.1,Toxicity to various agents,2,16831344
5,22.1,Diarrhoea,1,16831344
6,22.1,Nausea,2,16831344
7,22.1,Decreased appetite,2,16831344
0,22.0,Pancytopenia,6,16831345
1,22.0,Asthenia,3,16831345
0,22.1,Malignant neoplasm progression,6,16831367
1,22.1,Radiation pneumonitis,6,16831367
2,22.1,Brain oedema,6,16831367
3,22.1,Metastases to central nervous system,6,16831367
0,22.0,Rash erythematous,1,16831368
1,22.0,Nausea,6,16831368
2,22.0,Miliaria,6,16831368
0,22.0,Swelling,6,16831497
1,22.0,Erysipelas,1,16831497
2,22.0,Inflammation,6,16831497
3,22.0,Visual impairment,3,16831497
0,22.1,Pleural effusion,3,16831515
1,22.1,Pyrexia,1,16831515
2,22.1,Deep vein thrombosis,3,16831515
3,22.1,Deep vein thrombosis,3,16831515
0,22.0,Retinal tear,2,16831562
0,22.0,Foot deformity,1,16831571
0,22.1,Product availability issue,6,16831620
1,22.1,Product dose omission,6,16831620
2,22.1,Bladder cancer recurrent,3,16831620
0,22.0,Neutropenia,1,16831658
1,22.0,Pyrexia,1,16831658
0,22.1,Disease progression,,16831668
0,22.1,Feeling abnormal,,16831740
0,22.1,Death,,16831750
0,22.0,Ophthalmic vein thrombosis,6,16831752
1,22.0,Diarrhoea,6,16831752
0,22.0,Leukopenia,6,16831793
1,22.0,Hypertransaminasaemia,6,16831793
2,22.0,Neutropenia,6,16831793
0,22.0,Flushing,1,16831811
1,22.0,Hypertension,1,16831811
2,22.0,Erythema,1,16831811
0,22.1,Renal impairment,6,16831825
1,22.1,Neutropenia,6,16831825
2,22.1,Acute coronary syndrome,6,16831825
3,22.1,Thrombocytopenia,6,16831825
0,22.0,Blister,6,16831826
1,22.0,Alopecia,1,16831826
2,22.0,Fatigue,1,16831826
3,22.0,Eye disorder,3,16831826
4,22.0,Somnolence,6,16831826
5,22.0,Urticaria,3,16831826
6,22.0,Malignant neoplasm progression,6,16831826
7,22.0,Butterfly rash,3,16831826
8,22.0,Urticaria,1,16831826
9,22.0,Expired product administered,6,16831826
10,22.0,Diarrhoea,1,16831826
11,22.0,Diarrhoea,3,16831826
0,22.0,Diarrhoea,6,16831829
1,22.0,Dehydration,6,16831829
2,22.0,Nausea,6,16831829
0,22.0,Blood potassium decreased,6,16832032
1,22.0,Hepatic enzyme increased,6,16832032
0,22.0,Dysuria,3,16832045
1,22.0,Micturition urgency,3,16832045
2,22.0,Drug interaction,3,16832045
3,22.0,Cystitis noninfective,3,16832045
0,22.1,Leukopenia,2,16832067
1,22.1,Abdominal discomfort,1,16832067
2,22.1,Nausea,1,16832067
3,22.1,Lacrimation increased,1,16832067
4,22.1,Fatigue,1,16832067
5,22.1,Epistaxis,1,16832067
6,22.1,Thrombocytopenia,1,16832067
7,22.1,Anal incontinence,1,16832067
8,22.1,Pelvic floor muscle weakness,1,16832067
9,22.1,Alopecia,3,16832067
0,22.0,Urinary tract obstruction,6,16832099
1,22.0,Visual impairment,6,16832099
0,22.1,Liver disorder,6,16832135
1,22.1,Fistula,6,16832135
2,22.1,Pneumonia,5,16832135
0,22.1,Death,5,16832164
1,22.1,Intentional product use issue,6,16832164
0,22.1,Drug eruption,,16832232
1,22.1,Stevens-Johnson syndrome,,16832232
2,22.1,Toxic epidermal necrolysis,,16832232
0,22.1,Therapy cessation,,16832353
1,22.1,Hospitalisation,,16832353
0,22.0,Dyspepsia,4,16832769
0,22.0,Renal impairment,6,16832796
1,22.0,Bone marrow failure,6,16832796
2,22.0,Hepatic function abnormal,6,16832796
3,22.0,Cardiotoxicity,6,16832796
0,22.0,Radiation pneumonitis,2,16832811
0,22.0,Jaundice cholestatic,6,16832852
1,22.0,Bile duct obstruction,6,16832852
0,22.0,Blood urea increased,6,16832855
1,22.0,Malignant neoplasm progression,6,16832855
2,22.0,Renal impairment,6,16832855
0,22.0,Death,5,16832883
0,22.0,Neutrophil count decreased,6,16832899
1,22.0,Supraventricular tachycardia,6,16832899
2,22.0,Proteinuria,6,16832899
3,22.0,Diarrhoea,6,16832899
4,22.0,Pneumonitis,6,16832899
5,22.0,Asthenia,6,16832899
6,22.0,Intentional product use issue,6,16832899
7,22.0,Fatigue,6,16832899
8,22.0,Arrhythmia,6,16832899
9,22.0,Off label use,6,16832899
10,22.0,Hypertension,6,16832899
11,22.0,Sepsis,6,16832899
12,22.0,Bone marrow failure,6,16832899
13,22.0,Myocardial ischaemia,6,16832899
14,22.0,Abdominal pain,6,16832899
15,22.0,Febrile neutropenia,6,16832899
16,22.0,Dehydration,6,16832899
0,22.0,Drug ineffective,6,16832988
1,22.0,Malignant neoplasm progression,6,16832988
0,22.0,Myelodysplastic syndrome,5,16832989
0,22.0,Arrhythmia,1,16833049
1,22.0,Myocardial infarction,1,16833049
2,22.0,Ejection fraction decreased,6,16833049
0,22.0,Malignant neoplasm progression,6,16833062
0,22.0,Pruritus generalised,6,16833070
0,22.0,Colitis,6,16833096
1,22.0,Sepsis,6,16833096
0,22.0,Menopause,6,16833108
1,22.0,Deafness,6,16833108
0,22.0,Death,5,16833128
0,22.1,Disease progression,,16833146
0,22.1,Hospitalisation,,16833178
0,22.0,Death,5,16833197
0,22.0,Agranulocytosis,1,16833224
0,22.0,Agranulocytosis,1,16833227
0,22.0,Agranulocytosis,1,16833228
0,22.0,Agranulocytosis,1,16833230
0,22.0,Agranulocytosis,1,16833233
0,22.1,Prostate cancer metastatic,5,16833246
0,22.0,Death,5,16833262
0,22.1,Complication associated with device,,16833270
0,22.1,Extradural neoplasm,3,16833277
1,22.1,Death,5,16833277
0,22.0,Rash,3,16833285
1,22.0,Urinary tract inflammation,3,16833285
2,22.0,Pruritus generalised,3,16833285
3,22.0,Back pain,3,16833285
4,22.0,Bone pain,3,16833285
5,22.0,Dyspnoea,3,16833285
6,22.0,Nausea,3,16833285
7,22.0,Pyrexia,3,16833285
8,22.0,Influenza,3,16833285
9,22.0,Somnolence,3,16833285
10,22.0,Trichorrhexis,3,16833285
0,22.0,Metastases to bone,2,16833291
1,22.0,Malignant neoplasm progression,6,16833291
2,22.0,Breast cancer,2,16833291
0,22.0,Gait disturbance,3,16833319
1,22.0,Headache,3,16833319
0,22.1,Death,5,16833321
0,22.1,Therapy cessation,,16833337
1,22.1,Hospitalisation,,16833337
0,22.0,Decreased appetite,6,16833443
1,22.0,Gait disturbance,6,16833443
2,22.0,Joint swelling,6,16833443
3,22.0,Neck pain,6,16833443
4,22.0,Nausea,6,16833443
0,22.0,Somnolence,3,16833480
1,22.0,Dysgeusia,3,16833480
2,22.0,Nausea,3,16833480
3,22.0,Hyperglycaemia,3,16833480
4,22.0,Paraesthesia,3,16833480
5,22.0,Decreased appetite,3,16833480
6,22.0,Gastrointestinal motility disorder,3,16833480
7,22.0,Asthenia,3,16833480
8,22.0,Vomiting,3,16833480
0,22.0,Type 2 diabetes mellitus,6,16833512
0,22.1,Blood chloride decreased,3,16833554
1,22.1,Fatigue,3,16833554
2,22.1,Neutrophil count increased,3,16833554
3,22.1,Red cell distribution width increased,3,16833554
4,22.1,Abdominal distension,3,16833554
5,22.1,Blood glucose increased,3,16833554
6,22.1,Cellulitis,3,16833554
7,22.1,Haematocrit decreased,3,16833554
8,22.1,Nail discolouration,3,16833554
9,22.1,Blood pressure increased,3,16833554
10,22.1,Blood calcium decreased,3,16833554
11,22.1,Blood lactate dehydrogenase increased,3,16833554
12,22.1,Carbohydrate antigen 15-3 increased,3,16833554
13,22.1,Lymphocyte count decreased,3,16833554
14,22.1,Mean cell haemoglobin increased,3,16833554
15,22.1,Mean platelet volume decreased,3,16833554
16,22.1,Monocyte count increased,3,16833554
17,22.1,Platelet count decreased,3,16833554
18,22.1,Pneumonia,3,16833554
19,22.1,Urinary tract infection,3,16833554
20,22.1,Aspartate aminotransferase increased,3,16833554
21,22.1,Haemoglobin decreased,3,16833554
22,22.1,Infusion site erythema,3,16833554
23,22.1,Red blood cell count decreased,3,16833554
24,22.1,Weight decreased,3,16833554
25,22.1,Abdominal pain upper,3,16833554
26,22.1,Alanine aminotransferase increased,3,16833554
27,22.1,Diarrhoea,3,16833554
28,22.1,Dysgeusia,3,16833554
29,22.1,Hypoaesthesia,3,16833554
30,22.1,Neutrophil count decreased,3,16833554
31,22.1,Asthenia,3,16833554
32,22.1,Blood magnesium decreased,3,16833554
33,22.1,Condition aggravated,3,16833554
34,22.1,Eczema,3,16833554
35,22.1,Gastritis,3,16833554
36,22.1,Mean cell volume increased,3,16833554
37,22.1,Neuropathy peripheral,3,16833554
38,22.1,White blood cell count decreased,3,16833554
0,22.1,Hypotension,6,16833559
1,22.1,Decreased appetite,6,16833559
2,22.1,Constipation,6,16833559
3,22.1,Back pain,6,16833559
4,22.1,Product dose omission,6,16833559
5,22.1,Anaemia,2,16833559
6,22.1,Pain in extremity,6,16833559
7,22.1,Bone marrow failure,2,16833559
0,22.0,Type 2 diabetes mellitus,6,16833573
0,22.0,Type 2 diabetes mellitus,6,16833575
0,22.0,Type 2 diabetes mellitus,6,16833578
0,22.0,Dyspnoea,1,16833579
1,22.0,Non-cardiac chest pain,1,16833579
0,22.0,Death,5,16833583
0,22.0,Death,5,16833589
0,22.0,Type 2 diabetes mellitus,6,16833595
0,22.0,Death,5,16833596
0,22.0,Death,5,16833597
0,22.0,Respiratory distress,1,16833619
1,22.0,Pleurisy,1,16833619
2,22.0,Lung disorder,1,16833619
0,22.1,Lens dislocation,1,16833638
1,22.1,Cataract,1,16833638
2,22.1,Myopia,1,16833638
0,22.0,Malignant neoplasm progression,6,16833653
1,22.0,Malignant transformation,3,16833653
2,22.0,Small cell lung cancer,3,16833653
0,22.0,Fatigue,2,16833656
1,22.0,Cystitis,2,16833656
2,22.0,Colitis,2,16833656
3,22.0,Prostatic specific antigen increased,6,16833656
0,22.0,Anxiety,2,16833660
0,22.0,Oesophagitis,4,16833662
0,22.0,Diarrhoea,6,16833669
0,22.1,Hyponatraemia,1,16833674
0,22.0,Alanine aminotransferase increased,2,16833675
1,22.0,Hyperglycaemia,2,16833675
0,22.0,Dyspnoea,6,16833690
0,22.0,Neuropathy peripheral,1,16833702
1,22.0,White blood cell count decreased,1,16833702
2,22.0,Neutrophil count decreased,1,16833702
3,22.0,Anaphylactic reaction,1,16833702
0,22.0,Hypercholesterolaemia,6,16833713
1,22.0,Hypertriglyceridaemia,6,16833713
0,22.1,Pain,6,16833719
1,22.1,Drug effective for unapproved indication,6,16833719
2,22.1,Off label use,6,16833719
0,22.1,Hair disorder,3,16833738
1,22.1,Hair colour changes,3,16833738
2,22.1,Madarosis,3,16833738
3,22.1,Alopecia,3,16833738
4,22.1,Hair texture abnormal,3,16833738
0,22.1,Fatigue,1,16833739
1,22.1,Asthenia,6,16833739
2,22.1,Pyrexia,6,16833739
3,22.1,Malaise,3,16833739
4,22.1,Haemoglobin decreased,3,16833739
5,22.1,Blood count abnormal,2,16833739
6,22.1,Dizziness,1,16833739
7,22.1,Platelet count decreased,1,16833739
8,22.1,Pneumonia,6,16833739
9,22.1,Dyspnoea,1,16833739
10,22.1,Sepsis,6,16833739
11,22.1,Full blood count abnormal,6,16833739
12,22.1,White blood cell count decreased,3,16833739
0,22.1,Leukopenia,1,16833768
1,22.1,Neutropenia,1,16833768
0,22.1,Death,5,16833774
0,22.1,Death,5,16833776
1,22.1,Intentional product use issue,6,16833776
0,22.0,Deafness,6,16833804
0,22.0,Deafness,6,16833805
0,22.0,Withdrawal syndrome,3,16833832
1,22.0,Pain,3,16833832
2,22.0,Bone pain,3,16833832
3,22.0,Malaise,3,16833832
0,22.0,Death,5,16833833
1,22.0,Drug ineffective,6,16833833
0,22.0,Product adhesion issue,6,16833836
1,22.0,Drug ineffective,6,16833836
0,22.0,Malaise,6,16833851
0,22.1,Pain,1,16833852
1,22.1,White blood cell count decreased,1,16833852
2,22.1,Alopecia,1,16833852
3,22.1,Fatigue,1,16833852
4,22.1,Impaired healing,1,16833852
0,22.1,Dry mouth,1,16833915
1,22.1,Hyperglycaemia,1,16833915
2,22.1,Pollakiuria,1,16833915
0,22.1,Movement disorder,6,16833925
1,22.1,Hair disorder,6,16833925
2,22.1,Diarrhoea,2,16833925
3,22.1,Nausea,2,16833925
4,22.1,Vomiting,2,16833925
5,22.1,Decreased appetite,6,16833925
6,22.1,Neoplasm progression,6,16833925
0,22.1,Neutropenia,6,16833926
1,22.1,Cancer pain,6,16833926
2,22.1,Haemorrhage,6,16833926
3,22.1,Iron deficiency anaemia,6,16833926
0,22.0,Neutrophil count decreased,6,16833940
0,22.0,Amnesia,6,16833941
0,22.0,Full blood count decreased,6,16833944
1,22.0,Gait disturbance,6,16833944
2,22.0,Neoplasm recurrence,6,16833944
0,22.1,Fatigue,3,16833946
1,22.1,Back pain,3,16833946
0,22.0,Pruritus,6,16833965
1,22.0,Drug hypersensitivity,6,16833965
2,22.0,Swelling,6,16833965
0,22.0,White blood cell count decreased,6,16833966
0,22.0,Thrombocytopenia,1,16833989
1,22.0,Treatment noncompliance,6,16833989
2,22.0,Haematuria,1,16833989
3,22.0,Prostatic specific antigen increased,2,16833989
4,22.0,Disseminated intravascular coagulation,1,16833989
0,22.0,Decreased appetite,1,16834012
0,22.0,White blood cell count increased,6,16834017
0,22.0,Alopecia,6,16834026
1,22.0,Fatigue,6,16834026
0,22.1,Dizziness,6,16834036
1,22.1,Blood creatinine increased,6,16834036
2,22.1,Hypoglycaemia,6,16834036
3,22.1,Internal haemorrhage,6,16834036
4,22.1,Fatigue,6,16834036
5,22.1,Hypotension,6,16834036
6,22.1,Nausea,6,16834036
0,22.0,Drug interaction,6,16834049
1,22.0,Blood thyroid stimulating hormone increased,1,16834049
2,22.0,Malignant neoplasm progression,6,16834049
3,22.0,Medullary thyroid cancer,6,16834049
4,22.0,Hypothyroidism,1,16834049
5,22.0,Product use in unapproved indication,6,16834049
0,22.1,Pruritus,6,16834111
1,22.1,Skin discolouration,3,16834111
2,22.1,Dry skin,3,16834111
3,22.1,Skin disorder,6,16834111
4,22.1,White blood cell count decreased,1,16834111
5,22.1,Death,5,16834111
6,22.1,Scratch,6,16834111
0,22.1,Pneumonia,6,16834141
1,22.1,Malaise,6,16834141
2,22.1,White blood cell count decreased,2,16834141
0,22.0,Rash erythematous,3,16834157
0,22.1,Decreased immune responsiveness,6,16834200
1,22.1,Dizziness,6,16834200
2,22.1,Dyspnoea,6,16834200
3,22.1,Inflammation,6,16834200
4,22.1,Erythema,6,16834200
5,22.1,Gastritis,6,16834200
6,22.1,Pigmentation disorder,6,16834200
7,22.1,Photopsia,6,16834200
8,22.1,Weight decreased,6,16834200
9,22.1,Constipation,6,16834200
10,22.1,Alcohol poisoning,6,16834200
11,22.1,Vomiting,6,16834200
0,22.1,Thrombocytopenia,3,16834224
1,22.1,Alopecia,3,16834224
2,22.1,Paraesthesia,3,16834224
3,22.1,Dysgeusia,3,16834224
0,22.1,Dysgeusia,3,16834251
1,22.1,Thrombosis,6,16834251
2,22.1,Dysphonia,3,16834251
3,22.1,Blood pressure fluctuation,6,16834251
4,22.1,Diarrhoea,3,16834251
5,22.1,Pneumonia,6,16834251
6,22.1,Decreased appetite,3,16834251
7,22.1,Hypotension,5,16834251
8,22.1,Blood pressure increased,3,16834251
9,22.1,Somnolence,6,16834251
10,22.1,Asthenia,3,16834251
11,22.1,Weight decreased,3,16834251
12,22.1,Oxygen saturation decreased,5,16834251
13,22.1,Fatigue,3,16834251
14,22.1,Blood potassium decreased,6,16834251
0,22.0,Death,5,16834268
1,22.0,Neoplasm progression,6,16834268
0,22.1,Diarrhoea,2,16834273
1,22.1,Anal incontinence,1,16834273
2,22.1,Neuropathy peripheral,2,16834273
0,22.0,Exophthalmos,6,16834334
1,22.0,Thyroid disorder,6,16834334
0,22.0,Death,5,16834358
0,22.0,Oedema peripheral,,16834391
1,22.0,Death,5,16834391
2,22.0,Diarrhoea,,16834391
3,22.0,Anorectal disorder,,16834391
4,22.0,Proctalgia,,16834391
5,22.0,General physical health deterioration,,16834391
6,22.0,Drug intolerance,,16834391
7,22.0,Jaundice,,16834391
0,22.0,Hyperglycaemia,6,16834401
0,22.0,Rhabdomyolysis,5,16834407
1,22.0,Hypoglycaemia,5,16834407
2,22.0,Hypocalcaemia,5,16834407
0,22.0,Hepatotoxicity,2,16834432
1,22.0,Haematotoxicity,2,16834432
0,22.1,Malignant neoplasm progression,5,16834437
1,22.1,Nausea,6,16834437
2,22.1,Breast cancer metastatic,5,16834437
0,22.0,Respiratory failure,2,16834517
1,22.0,Pneumonitis,3,16834517
0,22.0,Death,5,16834567
0,22.1,Neutropenia,6,16834571
1,22.1,Gastrointestinal toxicity,6,16834571
2,22.1,Mucosal inflammation,6,16834571
3,22.1,Leukopenia,6,16834571
4,22.1,Dyspepsia,6,16834571
5,22.1,Weight decreased,6,16834571
6,22.1,Neuropathy peripheral,3,16834571
7,22.1,Disease progression,6,16834571
8,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16834571
9,22.1,Diarrhoea,6,16834571
10,22.1,Hypertension,1,16834571
11,22.1,Peritonsillar abscess,6,16834571
12,22.1,Condition aggravated,6,16834571
13,22.1,Skin toxicity,6,16834571
0,22.0,Metastases to lymph nodes,6,16834580
1,22.0,Malignant neoplasm progression,6,16834580
2,22.0,Breast cancer,6,16834580
3,22.0,Metastases to liver,6,16834580
0,22.0,Hepatocellular injury,3,16834595
1,22.0,Cholestasis,3,16834595
2,22.0,Hypothyroidism,3,16834595
0,22.1,Neutrophil count decreased,1,16834638
1,22.1,Malignant neoplasm progression,6,16834638
2,22.1,Metastases to peritoneum,6,16834638
3,22.1,Anaemia,1,16834638
0,22.1,Radiation pneumonitis,2,16834679
0,22.0,Colon cancer stage III,6,16834704
1,22.0,Neurotoxicity,6,16834704
2,22.0,Malignant neoplasm progression,6,16834704
3,22.0,Toxicity to various agents,6,16834704
0,22.1,C-reactive protein increased,3,16834714
1,22.1,Hyperthermia,3,16834714
2,22.1,Therapeutic product effect incomplete,6,16834714
3,22.1,Neuroleptic malignant syndrome,6,16834714
4,22.1,Blood creatine phosphokinase increased,1,16834714
5,22.1,Musculoskeletal stiffness,2,16834714
6,22.1,Pneumonia aspiration,6,16834714
0,22.1,Alopecia,3,16834718
1,22.1,Hair disorder,3,16834718
2,22.1,Hair texture abnormal,3,16834718
3,22.1,Hair colour changes,3,16834718
4,22.1,Madarosis,3,16834718
0,22.1,Fluid retention,6,16834740
1,22.1,Diarrhoea,6,16834740
2,22.1,Malaise,6,16834740
3,22.1,Abdominal injury,6,16834740
4,22.1,Peripheral swelling,6,16834740
5,22.1,Asthenia,6,16834740
6,22.1,Hypersomnia,6,16834740
0,22.0,Metastases to peritoneum,6,16834766
0,22.1,Breast cancer,6,16834768
0,22.0,Nephropathy,1,16834795
0,22.0,Ileus,5,16834822
0,22.0,Death,5,16834837
1,22.0,Malignant neoplasm progression,6,16834837
2,22.0,Intentional product use issue,6,16834837
0,22.0,Pruritus,6,16834868
1,22.0,Hepatotoxicity,1,16834868
2,22.0,Haematotoxicity,2,16834868
0,22.0,Neutropenia,1,16834911
1,22.0,Interstitial lung disease,1,16834911
2,22.0,Arthralgia,1,16834911
3,22.0,Pyrexia,1,16834911
4,22.0,Myalgia,1,16834911
0,22.1,Renal failure,1,16834941
1,22.1,Vasculitic rash,1,16834941
2,22.1,Rash,1,16834941
0,22.1,Erythema,1,16834975
1,22.1,Off label use,6,16834975
2,22.1,Hypertension,1,16834975
3,22.1,Flushing,1,16834975
0,22.0,Disseminated intravascular coagulation,5,16834976
1,22.0,Tumour haemorrhage,5,16834976
2,22.0,Hepatic atrophy,6,16834976
3,22.0,Hepatic failure,5,16834976
4,22.0,Varices oesophageal,6,16834976
0,22.0,Septic shock,5,16834978
0,22.0,Death,5,16834984
1,22.0,Off label use,6,16834984
0,22.0,Psychological trauma,6,16835019
1,22.0,Alopecia,2,16835019
0,22.0,Pain,6,16835020
1,22.0,Alopecia,3,16835020
2,22.0,Anxiety,6,16835020
3,22.0,Emotional distress,6,16835020
4,22.0,Impaired quality of life,6,16835020
0,22.1,Alopecia,3,16835022
1,22.1,Pain,6,16835022
2,22.1,Psychological trauma,6,16835022
3,22.1,Impaired quality of life,6,16835022
4,22.1,Emotional distress,6,16835022
5,22.1,Anxiety,6,16835022
0,22.0,Alopecia,2,16835033
1,22.0,Psychological trauma,6,16835033
0,22.1,Alopecia,2,16835052
0,22.1,Anxiety,6,16835150
1,22.1,Alopecia,2,16835150
2,22.1,Impaired quality of life,6,16835150
3,22.1,Emotional distress,6,16835150
4,22.1,Pain,6,16835150
0,22.1,Alopecia,2,16835158
0,22.1,Impaired quality of life,6,16835159
1,22.1,Psychological trauma,6,16835159
2,22.1,Emotional distress,6,16835159
3,22.1,Alopecia,2,16835159
4,22.1,Anxiety,6,16835159
5,22.1,Pain,6,16835159
0,22.1,Psychological trauma,6,16835164
1,22.1,Emotional distress,6,16835164
2,22.1,Impaired quality of life,6,16835164
3,22.1,Anxiety,6,16835164
4,22.1,Alopecia,2,16835164
5,22.1,Pain,6,16835164
0,22.1,Emotional distress,6,16835174
1,22.1,Alopecia,3,16835174
2,22.1,Pain,6,16835174
3,22.1,Anxiety,6,16835174
4,22.1,Psychological trauma,6,16835174
5,22.1,Impaired quality of life,6,16835174
0,22.0,Incorrect product administration duration,6,16835183
0,22.0,Myalgia,3,16835195
1,22.0,Dyspnoea,6,16835195
2,22.0,Blood pressure fluctuation,6,16835195
3,22.0,Tremor,6,16835195
4,22.0,Asthenia,6,16835195
5,22.0,Glycosylated haemoglobin increased,6,16835195
6,22.0,Back pain,3,16835195
7,22.0,Diarrhoea,6,16835195
8,22.0,Blood pressure increased,3,16835195
9,22.0,Blood glucose increased,6,16835195
10,22.0,White blood cell count increased,6,16835195
11,22.0,Nausea,1,16835195
12,22.0,Hypotension,6,16835195
13,22.0,Adverse event,6,16835195
14,22.0,Pyrexia,6,16835195
15,22.0,Bone pain,3,16835195
16,22.0,Red blood cell count decreased,6,16835195
17,22.0,Nasopharyngitis,6,16835195
18,22.0,Fatigue,3,16835195
0,22.0,Contrast media reaction,1,16835214
0,22.1,Death,5,16835219
0,22.1,Febrile neutropenia,6,16835254
1,22.1,Leukopenia,6,16835254
2,22.1,Malignant neoplasm progression,6,16835254
3,22.1,Neutropenia,6,16835254
4,22.1,Enteritis,6,16835254
5,22.1,Fatigue,6,16835254
6,22.1,Skin toxicity,6,16835254
7,22.1,Gastrointestinal disorder,6,16835254
8,22.1,Diarrhoea,6,16835254
9,22.1,Mucosal inflammation,6,16835254
10,22.1,Anaemia,6,16835254
11,22.1,Gene mutation,6,16835254
12,22.1,Asthenia,6,16835254
13,22.1,Hypomagnesaemia,6,16835254
0,22.1,Parosmia,6,16835716
1,22.1,Nausea,6,16835716
2,22.1,Weight decreased,3,16835716
3,22.1,Condition aggravated,6,16835716
4,22.1,Diarrhoea,3,16835716
5,22.1,Disease progression,6,16835716
6,22.1,Fatigue,3,16835716
7,22.1,Limb discomfort,6,16835716
8,22.1,Ascites,3,16835716
9,22.1,Blood magnesium decreased,6,16835716
10,22.1,Abdominal pain upper,6,16835716
11,22.1,Constipation,6,16835716
12,22.1,Malaise,6,16835716
13,22.1,Abdominal distension,6,16835716
14,22.1,Hypergeusia,6,16835716
15,22.1,Abdominal pain lower,6,16835716
16,22.1,Abdominal rigidity,6,16835716
17,22.1,Intestinal obstruction,5,16835716
18,22.1,Decreased appetite,3,16835716
19,22.1,Somnolence,6,16835716
0,22.0,Dizziness,6,16835717
1,22.0,Vomiting,6,16835717
2,22.0,Drug ineffective,6,16835717
3,22.0,Fatigue,6,16835717
4,22.0,Gout,6,16835717
5,22.0,Urinary tract infection,6,16835717
0,22.0,Infection,6,16835779
0,22.1,Ill-defined disorder,6,16835787
1,22.1,Hospitalisation,6,16835787
0,22.0,Blood count abnormal,6,16835789
1,22.0,Decreased appetite,6,16835789
2,22.0,Polyuria,3,16835789
3,22.0,Nausea,6,16835789
0,22.1,Contusion,1,16835790
1,22.1,Nausea,3,16835790
2,22.1,Blood blister,1,16835790
3,22.1,Feeding disorder,1,16835790
4,22.1,Decreased appetite,1,16835790
5,22.1,Thrombocytopenia,1,16835790
6,22.1,Petechiae,1,16835790
7,22.1,Weight decreased,2,16835790
8,22.1,Fatigue,3,16835790
9,22.1,Anaemia,6,16835790
10,22.1,Carbohydrate antigen 125 increased,3,16835790
11,22.1,Hepatic lesion,6,16835790
0,22.0,Glioblastoma multiforme,6,16835793
1,22.0,Fatigue,6,16835793
2,22.0,Asthenia,6,16835793
3,22.0,Mental impairment,6,16835793
4,22.0,Nausea,6,16835793
5,22.0,Dizziness,6,16835793
0,22.1,Platelet count decreased,1,16835794
1,22.1,Cataract,6,16835794
0,22.1,Oral mucosal blistering,3,16835796
1,22.1,Feeling hot,1,16835796
2,22.1,Decreased appetite,2,16835796
3,22.1,Vomiting,1,16835796
4,22.1,Vaginal neoplasm,3,16835796
5,22.1,Night sweats,1,16835796
6,22.1,Abdominal discomfort,1,16835796
7,22.1,Fatigue,2,16835796
8,22.1,Hypoaesthesia,6,16835796
9,22.1,Oral pain,3,16835796
10,22.1,Paranasal sinus hypersecretion,6,16835796
11,22.1,Platelet count decreased,2,16835796
12,22.1,Pleural effusion,6,16835796
13,22.1,Carbohydrate antigen 125 increased,3,16835796
14,22.1,Pneumonia,1,16835796
15,22.1,Dysgeusia,1,16835796
16,22.1,Product dose omission,6,16835796
17,22.1,Swollen tongue,3,16835796
18,22.1,Lymphadenopathy mediastinal,6,16835796
19,22.1,Hypotension,3,16835796
20,22.1,Stomatitis,1,16835796
21,22.1,Asthenia,2,16835796
22,22.1,Constipation,1,16835796
23,22.1,Underdose,6,16835796
24,22.1,Hyperhidrosis,3,16835796
25,22.1,Weight decreased,6,16835796
26,22.1,Feeling abnormal,6,16835796
27,22.1,Cardiac failure,6,16835796
28,22.1,Lip pain,6,16835796
29,22.1,Tongue disorder,1,16835796
30,22.1,Pulmonary mass,6,16835796
31,22.1,Insomnia,3,16835796
32,22.1,Nausea,1,16835796
33,22.1,Dyspnoea exertional,3,16835796
0,22.1,Oral mucosal blistering,3,16835798
1,22.1,Oropharyngeal blistering,3,16835798
2,22.1,Feeding disorder,6,16835798
3,22.1,Hospice care,6,16835798
0,22.1,Red blood cell count decreased,6,16835799
1,22.1,Emotional distress,3,16835799
2,22.1,Stress urinary incontinence,6,16835799
3,22.1,Anxiety,6,16835799
4,22.1,Recurrent cancer,6,16835799
5,22.1,Insomnia,6,16835799
6,22.1,Blood magnesium decreased,6,16835799
7,22.1,Red cell distribution width increased,6,16835799
8,22.1,Laboratory test abnormal,6,16835799
9,22.1,Carbohydrate antigen 125 increased,6,16835799
10,22.1,Hepatic enzyme increased,6,16835799
11,22.1,Nausea,3,16835799
12,22.1,Underdose,6,16835799
13,22.1,Hydronephrosis,6,16835799
14,22.1,Increased appetite,6,16835799
0,22.1,Vomiting,1,16835800
1,22.1,Clostridium difficile infection,1,16835800
0,22.1,Fatigue,3,16835802
1,22.1,Gait disturbance,6,16835802
2,22.1,Blood calcium increased,3,16835802
3,22.1,Secretion discharge,6,16835802
4,22.1,Blood calcium decreased,6,16835802
5,22.1,Asthenia,3,16835802
6,22.1,Product use in unapproved indication,6,16835802
7,22.1,Recurrent cancer,6,16835802
8,22.1,Lower respiratory tract infection,1,16835802
9,22.1,Dry eye,3,16835802
10,22.1,Nasopharyngitis,1,16835802
11,22.1,Constipation,1,16835802
12,22.1,Vision blurred,3,16835802
13,22.1,Blood urea increased,6,16835802
14,22.1,Oedema peripheral,3,16835802
15,22.1,Taste disorder,3,16835802
16,22.1,Blood pressure increased,3,16835802
17,22.1,Computerised tomogram abnormal,6,16835802
18,22.1,Vitreous floaters,6,16835802
0,22.1,Platelet count decreased,2,16835829
1,22.1,White blood cell count decreased,3,16835829
2,22.1,Constipation,6,16835829
3,22.1,Red blood cell count decreased,6,16835829
4,22.1,Dry mouth,6,16835829
0,22.1,Muscle spasms,6,16835830
1,22.1,Surgery,6,16835830
2,22.1,Abdominal pain,3,16835830
3,22.1,Hospitalisation,6,16835830
4,22.1,Sleep disorder,2,16835830
5,22.1,Cognitive disorder,3,16835830
6,22.1,Urinary tract infection,6,16835830
7,22.1,Constipation,2,16835830
8,22.1,Contusion,3,16835830
0,22.1,Feeling abnormal,6,16835832
1,22.1,Temperature intolerance,6,16835832
2,22.1,Tinnitus,6,16835832
3,22.1,Nausea,3,16835832
4,22.1,Constipation,6,16835832
5,22.1,Carbohydrate antigen 125 increased,3,16835832
6,22.1,Faeces soft,6,16835832
7,22.1,Dysphonia,6,16835832
8,22.1,Red blood cell count decreased,6,16835832
9,22.1,Deafness,6,16835832
10,22.1,Pain in extremity,6,16835832
11,22.1,Hyperhidrosis,6,16835832
12,22.1,Cheilitis,3,16835832
13,22.1,Oral fungal infection,6,16835832
14,22.1,Fatigue,3,16835832
15,22.1,Muscle spasms,6,16835832
16,22.1,Dyspnoea,3,16835832
17,22.1,Dizziness postural,6,16835832
18,22.1,Decreased appetite,6,16835832
0,22.0,Pulmonary embolism,6,16835836
1,22.0,Anaemia,6,16835836
0,22.1,Encephalitis,2,16835872
0,22.1,Breast cancer metastatic,3,16835884
1,22.1,Malignant neoplasm progression,3,16835884
0,22.0,Bladder cancer recurrent,6,16835891
0,22.1,Malaise,6,16835913
0,22.0,Hypertension,6,16835924
1,22.0,Diarrhoea,6,16835924
2,22.0,Weight decreased,6,16835924
0,22.0,Agranulocytosis,1,16835995
0,22.0,Bone marrow failure,1,16835996
1,22.0,Bone marrow failure,1,16835996
0,22.0,Agranulocytosis,1,16836000
0,22.0,Agranulocytosis,1,16836001
0,22.0,Agranulocytosis,1,16836005
0,22.0,Agranulocytosis,1,16836011
0,22.0,Bone marrow failure,6,16836012
1,22.0,Agranulocytosis,1,16836012
2,22.0,Leukopenia,1,16836012
0,22.0,Death,5,16836028
0,22.1,Pathological fracture,6,16836038
1,22.1,Immune-mediated hepatitis,2,16836038
0,22.1,Adverse event,1,16836083
0,22.1,Iron deficiency,1,16836101
1,22.1,Alopecia,3,16836101
2,22.1,Mucosal inflammation,1,16836101
3,22.1,Diplopia,1,16836101
4,22.1,Inflammation,1,16836101
5,22.1,Dermal cyst,1,16836101
0,22.0,Proctitis,6,16836102
0,22.0,Hyperglycaemia,1,16836107
0,22.1,Rash,3,16836126
1,22.1,Pneumonitis,3,16836126
2,22.1,Hyperglycaemia,3,16836126
3,22.1,Dyspnoea,3,16836126
0,22.1,Blood glucose increased,2,16836145
0,22.0,Neuropathy peripheral,6,16836167
0,22.1,Hypertensive crisis,1,16836175
1,22.1,Dizziness,3,16836175
2,22.1,Nausea,1,16836175
3,22.1,Neutropenia,1,16836175
0,22.1,Hypoaesthesia,6,16836195
1,22.1,Hyperglycaemia,6,16836195
0,22.0,Disease progression,6,16836218
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16836218
0,22.0,Klebsiella infection,6,16836234
1,22.0,Off label use,6,16836234
2,22.0,Lymphocyte count decreased,6,16836234
0,22.0,Pneumonitis,6,16836250
0,22.1,Fatigue,5,16836297
1,22.1,Constipation,5,16836297
2,22.1,Decreased appetite,5,16836297
3,22.1,Laboratory test abnormal,5,16836297
4,22.1,Hyperhidrosis,5,16836297
5,22.1,Asthenia,5,16836297
0,22.0,Hyperbilirubinaemia,6,16836302
1,22.0,Off label use,6,16836302
0,22.0,Vascular pseudoaneurysm,1,16836308
0,22.0,Neutropenia,6,16836313
0,22.0,Memory impairment,6,16836317
0,22.0,Acute myeloid leukaemia,2,16836327
1,22.0,Osteonecrosis of jaw,6,16836327
2,22.0,Second primary malignancy,2,16836327
0,22.1,Carbohydrate antigen 19-9 increased,2,16836328
1,22.1,Gastrointestinal toxicity,6,16836328
2,22.1,Hepatic necrosis,6,16836328
3,22.1,Rash pustular,6,16836328
4,22.1,Metastases to liver,6,16836328
5,22.1,Hypertension,2,16836328
6,22.1,Carcinoembryonic antigen increased,2,16836328
7,22.1,PIK3CA-activated mutation,6,16836328
8,22.1,Disease progression,6,16836328
0,22.1,Death,5,16836333
1,22.1,Extremity necrosis,6,16836333
0,22.1,Meningitis aseptic,6,16836370
0,22.1,Erythema,1,16836443
1,22.1,Hypertensive crisis,1,16836443
2,22.1,Flushing,1,16836443
3,22.1,Hypertension,1,16836443
0,22.1,Asthenia,3,16836491
1,22.1,Blood count abnormal,6,16836491
2,22.1,Hypersomnia,3,16836491
3,22.1,General physical health deterioration,5,16836491
4,22.1,Malaise,6,16836491
5,22.1,Oedema peripheral,3,16836491
6,22.1,Nausea,3,16836491
0,22.1,Alopecia,3,16836526
1,22.1,Paraesthesia,3,16836526
2,22.1,Thrombocytopenia,3,16836526
3,22.1,Dysgeusia,3,16836526
0,22.1,Neutropenia,6,16836535
1,22.1,Haemorrhage,6,16836535
2,22.1,Pruritus,6,16836535
0,22.0,Rash,3,16836569
0,22.1,Rash,3,16836574
0,22.1,Septic shock,5,16836579
1,22.1,Pain,6,16836579
2,22.1,Hypotension,5,16836579
3,22.1,Organ failure,6,16836579
4,22.1,Blood calcium decreased,6,16836579
5,22.1,Muscle atrophy,6,16836579
6,22.1,Condition aggravated,6,16836579
7,22.1,Mobility decreased,3,16836579
8,22.1,Blood phosphorus decreased,6,16836579
9,22.1,Hallucination,6,16836579
10,22.1,Weight decreased,6,16836579
11,22.1,Pneumonia,5,16836579
12,22.1,Joint dislocation,6,16836579
13,22.1,Bedridden,6,16836579
0,22.0,Alanine aminotransferase increased,3,16836588
0,22.0,Colon cancer,5,16836664
1,22.0,Taste disorder,6,16836664
0,22.1,Tinnitus,3,16836690
1,22.1,Deafness,3,16836690
0,22.0,Cognitive disorder,2,16836691
1,22.0,Diarrhoea,2,16836691
0,22.1,Stomatitis,5,16836692
1,22.1,Oesophagitis,5,16836692
2,22.1,Neutropenia,5,16836692
0,22.0,Hepatotoxicity,1,16836742
0,22.0,Chronic myelomonocytic leukaemia,6,16836778
0,22.0,Hepatocellular injury,1,16836804
1,22.0,Gamma-glutamyltransferase increased,1,16836804
2,22.0,Aspartate aminotransferase increased,1,16836804
3,22.0,Alanine aminotransferase increased,1,16836804
0,22.0,Rash,3,16836810
0,22.0,Neuropathy peripheral,6,16836863
0,22.1,Adverse event,6,16836897
1,22.1,Intentional product use issue,6,16836897
0,22.0,Vomiting,2,16836918
1,22.0,Chromaturia,1,16836918
2,22.0,Bone marrow failure,2,16836918
0,22.0,Nausea,1,16836919
1,22.0,Abdominal discomfort,2,16836919
2,22.0,Bone marrow failure,2,16836919
3,22.0,Hypophagia,6,16836919
4,22.0,Nausea,1,16836919
5,22.0,Vomiting,6,16836919
0,22.0,Embolic stroke,4,16836937
1,22.0,Facial paralysis,6,16836937
2,22.0,Aphasia,6,16836937
0,22.0,Bone marrow failure,2,16836943
1,22.0,Decreased appetite,2,16836943
2,22.0,Vomiting,1,16836943
3,22.0,Nausea,1,16836943
0,22.0,Cardiac dysfunction,6,16836948
